hypercholesterolemia
Showing 1 - 25 of 690
Hypercholesterolemia, Primary Prevention Trial in Sao Paulo (Phytosterol supplements)
Completed
- Hypercholesterolemia
- Primary Prevention
- Phytosterol supplements
-
Sao Paulo, Other, Brazil
- +1 more
Nov 9, 2023
l Gene Editing Therapy for Cardiovascular Disease
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
-
Auckland, New Zealand
- +2 more
Oct 31, 2023
Cardiovascular Diseases, Hypertension, Diabetes Trial in New Orleans (Evidence-based interventions recommended by the 2019
Not yet recruiting
- Cardiovascular Diseases
- +3 more
- Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
-
New Orleans, LouisianaTulane University
Sep 26, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Hypercholesterolemia, Dyslipidemias Trial in Hamburg (lipodia)
Not yet recruiting
- Hypercholesterolemia
- Dyslipidemias
- lipodia
-
Hamburg, GermanyGAIA AG
Aug 3, 2023
Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)
Not yet recruiting
- Hypercholesterolemia
- Familial Hypercholesterolemia
- MK-0616
- Placebo
- (no location specified)
Jul 10, 2023
Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)
Not yet recruiting
- Hypercholesterolemia
- Familial Hypercholesterolemia
- MK-0616
- Placebo
- (no location specified)
Jul 10, 2023
Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))
Recruiting
- Hypercholesterolemia
- K-877 0.2 mg/day (once daily)
- +2 more
-
Aichi, Japan
- +14 more
Jun 20, 2023
Cardiovascular Diseases, Hypercholesterolemia, Atherosclerosis Trial (PS-containing dietary supplement, Placebo)
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- PS-containing dietary supplement
- Placebo
- (no location specified)
Jun 2, 2023
Hyperlipidemias, Hypercholesterolemia Trial in Chios (Chios Mastiha essential oil, Placebo)
Completed
- Hyperlipidemias
- Hypercholesterolemia
- Chios Mastiha essential oil
- Placebo
-
Chios, GreeceSkylitseio General Hospital
May 11, 2023
oncRNA Stratification of Cancer by Size and Stage
Not yet recruiting
- Kidney Cancer
- +32 more
- Exai oncRNA blood test
- (no location specified)
Apr 27, 2023
Hypercholesterolemia Trial in Guanzhou (Swisse plus cholesterol capsule, Placebo)
Not yet recruiting
- Hypercholesterolemia
- Swisse plus cholesterol capsule
- Placebo
-
Guanzhou, Guangdong, ChinaSunYat-senU
Apr 28, 2023
Hypercholesterolemia, Obesity, Diabetes Trial (smartphone health application (Opulse))
Not yet recruiting
- Hypercholesterolemia
- +3 more
- smartphone health application (Opulse)
- (no location specified)
Mar 23, 2023
Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)
Not yet recruiting
- Hypercholesterolemia
- HSK31679 low dose
- +4 more
- (no location specified)
Mar 20, 2023
Hypercholesterolemia Trial in Sydney, Morayfield, Melbourne (VXX-401, Placebo)
Recruiting
- Hypercholesterolemia
- VXX-401
- Placebo
-
Sydney, New South Wales, Australia
- +2 more
Mar 15, 2023
Hypercholesterolemia Trial in Clermont-ferrand, Clermont-Ferrand, Durtol (LIMICOL, PLACEBO)
Completed
- Hypercholesterolemia
- LIMICOL
- PLACEBO
-
Clermont-ferrand, France
- +3 more
Feb 28, 2023
Diet-induced Elevations in LDL-C and Progression of
Recruiting
- Hypercholesterolemia
-
Torrance, CaliforniaLundquist Institute for Biomedical Innovation at Harbor UCLA Med
Feb 17, 2023
Time Restricted Feeding, Overweight and Obesity, Inflammation Trial in Izola (Effects of calorie restriction and time-restricted
Recruiting
- Time Restricted Feeding
- +8 more
- Effects of calorie restriction and time-restricted eating on human health
-
Izola, SloveniaUniversity of Primorska, Faculty of Health Sciences
Feb 6, 2023
Inclisiran and Other Lipid Lowering Treatments inReal-world
Recruiting
- Hypercholesterolemia
- Inclisiran
-
Freudenstadt, Baden Wuerttemberg, Germany
- +94 more
Jan 24, 2023
Hypercholesterolemia Trial in Saint Louis (Bempedoic acid)
Recruiting
- Hypercholesterolemia
- Bempedoic acid
-
Saint Louis, MissouriWashington University School of Medicine, Division of Endocrinol
Jan 12, 2023
Lipoprotein Metabolism in Normal Volunteers and High Levels of
Completed
- Hypolipoproteinemia
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)
Not yet recruiting
- Hypercholesterolemia
- +3 more
- Inclisiran
- +2 more
-
Cambridge, United KingdomUniversity of Cambridge
Jan 13, 2023
Cognitive Function in Patients Treated With PCSK9 Inhibitors
Completed
- Cognitive Function
- +2 more
- PCSK9 inhibitor
-
Cee, A Coruña, Spain
- +11 more
Jan 13, 2023
Hypercholesterolemia Trial in Edmonton (Kefir)
Completed
- Hypercholesterolemia
- Kefir
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jan 11, 2023